Law Offices of Thomas J. Lamb

  • Asbestos & Mesothelioma
  • Benzene Diseases
  • Drug Injury
  • About Our Firm
  • Free Case Evaluation
  • Frequently Asked Questions

Picato Skin Cancer Risk Confirmed In Europe; FDA Picato Review Ongoing

April 24, 2020 By Law Offices of Thomas J. Lamb, P.A.

In April 2020 the European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) confirmed that Picato increased risk of skin cancer findings outweigh Picato’s benefits as a treatment of actinic keratosis. We previously provided some background for this Picato drug safety issue in this January 2020 Drug Injury Watch blog article, “Picato Skin Cancer Risk Investigation By European Drug Regulator Prompts Sales Suspension In Europe”.

An Arpil 17, 2020 European Medicines Agency (EMA) press release, “EMA review of Picato concludes medicine’s risks outweigh its benefits”, noted the Picato increased risk of skin cancer findings in comparison to another actinic keratosis treatment, imiquimod.  That April 2020 EMA Picato press release went on to point out:

The study showed a higher occurrence of skin cancers, especially squamous cell carcinoma, in areas of skin treated with Picato than in areas treated with imiquimod….

Patients who have been treated with Picato should look out for unusual skin changes or growths, which may occur from weeks to months after use, and seek medical advice if any occur.

As mentioned in our January 2020 article about this Picato skin cancer risk, the FDA is investigating this Picato drug safety issue. We will monitor the FDA Picato investigation for any significant drug regulatory actions such as a Picato recall or Picato drug label change with new warnings about the skin cancer risk.

[Read article in full at original source]


Picato

Free Case Evaluation

Strictly Confidential, No Obligation

Filed Under: Unsafe Drugs Tagged With: Picato, Skin Cancer

Find What You Want Here

Get Free Case Evaluation

We encourage you to submit an online Case Evaluation Form form – it is confidential and there is no obligation.

Or call our toll-free number, 800-426-9535, to speak directly to attorney Tom Lamb about your possible case.

Feel Free To Contact Us

Quick Contact Form
 
Send an Email to Tom Lamb

(800) 426-9535

Main Navigation Menu

  • About Our Firm
  • Asbestos-Mesothelioma Cases
  • Benzene Disease Claims
  • Drug Injury Cases
  • Breast Implant Cases
  • Philips Breathing Devices Cases
  • GenX Cancer Cases
  • Case Evaluation Menu
  • Quick Contact Form
  • Frequently Asked Questions
  • Medical Records Charges
  • Collection of Articles
  • Sitemap

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Websites

Drug Injury Law
Drug Injury Watch
Drug Safety Developments
Asbestos & Mesothelioma

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Frequently Asked Questions
  • Disclaimer and Copyright Notices

Copyright © 2022 · Law Offices of Thomas J. Lamb, P.A.